SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-065295
Filing Date
2006-12-15
Accepted
2006-12-15 17:30:51
Documents
1
Period of Report
2006-12-13

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bsf25900_bsf3di.html 4  
1 MAIN DOCUMENT DESCRIPTION bsf25900_bsf3di.xml 4 4023
  Complete submission text file 0001209191-06-065295.txt   5914
Mailing Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804
Business Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SANGAMO BIOSCIENCES, INC. 501 CANAL BLVD SUITE A-100 RICHMOND CA 94804
Business Address 510-970-6000
Ichikawa David G (Reporting) CIK: 0001324506 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 061281516